Published in Hum Genet on January 01, 1981
Attenuated variants of Lesch-Nyhan disease. Brain (2010) 2.80
Genotype-phenotype correlations in neurogenetics: Lesch-Nyhan disease as a model disorder. Brain (2013) 1.17
Molecular basis of hypoxanthine-guanine phosphoribosyltransferase deficiency in a patient with the Lesch-Nyhan syndrome. J Clin Invest (1983) 1.05
Analysis of abnormalities in purine metabolism leading to gout and to neurological dysfunctions in man. Biochem J (1998) 1.04
Genotype-phenotype correlations in Lesch-Nyhan disease: moving beyond the gene. J Biol Chem (2011) 0.95
Mechanisms for phenotypic variation in Lesch-Nyhan disease and its variants. Hum Genet (2010) 0.87
Effect of hypoxanthine, antioxidants and allopurinol on cholinesterase activities in rats. J Neural Transm (Vienna) (2013) 0.77
Phenotypic variation among seven members of one family with deficiency of hypoxanthine-guanine phosphoribosyltransferase. Mol Genet Metab (2013) 0.75
Neuropsychological impairment in amateur soccer players. JAMA (1999) 4.60
Polo-like kinase-1 is a target of the DNA damage checkpoint. Nat Cell Biol (2000) 3.49
Determinants of success of inpatient clinical information systems: a literature review. J Am Med Inform Assoc (2003) 2.93
Chronic traumatic brain injury in professional soccer players. Neurology (1998) 2.25
Purine nucleoside phosphorylase deficiency associated with selective cellular immunodeficiency. N Engl J Med (1977) 2.12
Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product. Cancer Res (1992) 2.00
c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis. J Pathol (1996) 1.75
The validity of the Beck Depression Inventory as a screening and diagnostic instrument for depression in patients with Parkinson's disease. Mov Disord (2000) 1.65
Identification of connexin43 as a functional target for Wnt signalling. J Cell Sci (1998) 1.64
Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency. J Clin Invest (1978) 1.61
Redox regulation of signal transduction: tyrosine phosphorylation and calcium influx. Proc Natl Acad Sci U S A (1994) 1.55
p21 inhibits Thr161 phosphorylation of Cdc2 to enforce the G2 DNA damage checkpoint. J Biol Chem (2000) 1.44
[Cervical myelopathy as complication of manual therapy in a patient with a narrow cervical canal]. Ned Tijdschr Geneeskd (1993) 1.43
[Value of treatment of low-grade glioma still controversial]. Ned Tijdschr Geneeskd (1994) 1.39
p21waf1 can block cells at two points in the cell cycle, but does not interfere with processive DNA-replication or stress-activated kinases. Oncogene (1998) 1.38
[A case of fraud in a neurological pharmaceutical clinical trial]. Ned Tijdschr Geneeskd (2003) 1.38
Overexpression of EGFR and c-erbB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts. FEBS Lett (1998) 1.36
A dose-response relation of headers and concussions with cognitive impairment in professional soccer players. J Clin Exp Neuropsychol (2001) 1.31
Purification and properties of glutathione reductase of human erythrocytes. Biochim Biophys Acta (1969) 1.31
Human erythrocyte pyruvate kinase. Its purification and some properties. Biochim Biophys Acta (1971) 1.25
Characterization of alpha-L-fucosidase from two different families with fucosidosis. Clin Chim Acta (1976) 1.20
Positivity of the proliferation marker Ki-67 in noncycling cells. Am J Clin Pathol (1998) 1.17
Safety and tolerability of linagliptin: a pooled analysis of data from randomized controlled trials in 3572 patients with type 2 diabetes mellitus. Diabetes Obes Metab (2012) 1.08
Grb2 overexpression in nuclei and cytoplasm of human breast cells: a histochemical and biochemical study of normal and neoplastic mammary tissue specimens. J Pathol (1997) 1.07
[Thrombolytic therapy in patients with acute brain infarction: favorable preliminary results in Maastricht]. Ned Tijdschr Geneeskd (2000) 1.07
Development and implementation of an EPR: how to encourage the user. Int J Med Inform (2001) 1.06
An abnormal form of purine nucleoside phosphorylase in a family with a child with severe defective T-cell-and normal B-cell immunity. Clin Chim Acta (1976) 1.03
Tyrosine kinase activity in breast cancer, benign breast disease, and normal breast tissue. Cancer Res (1989) 1.01
Overexpression of c-Src in areas of hyperproliferation in head and neck cancer, premalignant lesions and benign mucosal disorders. J Oral Pathol Med (1998) 1.01
Pyruvate kinase activity and isozyme composition in normal fibrous tissue and fibroblastic proliferations. Cancer (1991) 1.00
Methotrexate transport in variant human CCRF-CEM leukemia cells with elevated levels of the reduced folate carrier. Selective effect on carrier-mediated transport of physiological concentrations of reduced folates. J Biol Chem (1990) 0.99
The antibody MY4 recognizes CD14 on porcine monocytes and macrophages. Scand J Immunol (1994) 0.99
CD28 induces cell cycle progression by IL-2-independent down-regulation of p27kip1 expression in human peripheral T lymphocytes. Eur J Immunol (1999) 0.99
Purification and some properties of human erythrocyte hexokinase. Biochim Biophys Acta (1976) 0.99
Gammahydroxybutyrate and narcolepsy: a double-blind placebo-controlled study. Sleep (1993) 0.97
The reaction mechanism of glutathione reductase from human erythrocytes. Biochim Biophys Acta (1969) 0.97
Isoenzymes of phosphofructokinase in the rat. Demonstration of the three non-identical subunits by biochemical, immunochemical and kinetic studies. Biochem J (1985) 0.96
Glycolytic enzyme activities in breast cancer metastases. Tumour Biol (1988) 0.96
Studies on hair roots for carrier detection in hypoxanthine-quanine phosphoribosyl transferase deficiency. Clin Genet (1974) 0.95
Child psychiatric diagnoses in a population of Dutch schoolchildren aged 6 to 8 years. J Am Acad Child Adolesc Psychiatry (2001) 0.93
Erythrocyte metabolism in purine nucleoside phosphorylase deficiency after enzyme replacement therapy by infusion of erythrocytes. J Clin Invest (1980) 0.93
Expression of a folate binding protein in L1210 cells grown in low folate medium. Cancer Res (1989) 0.93
Regulation of human erythrocyte hexokinase. The influence of glycolytic intermediates and inorganic phosphate. Biochim Biophys Acta (1977) 0.92
Membrane transport of natural folates and antifolate compounds in murine L1210 leukemia cells: role of carrier- and receptor-mediated transport systems. Cancer Res (1991) 0.92
Genomic organization and molecular characterization of a gene encoding HsPXF, a human peroxisomal farnesylated protein. Genomics (1997) 0.92
Glycolytic enzymes in breast cancer, benign breast disease and normal breast tissue. Tumour Biol (1987) 0.91
Subunit composition, regulatory properties, and phosphorylation of phosphofructokinase from human gliomas. Cancer Res (1987) 0.91
Forearm vascular response to nitric oxide and calcitonin gene-related peptide: comparison between migraine patients and control subjects. Cephalalgia (2006) 0.91
Hypoxanthine-guanine-phosphoribosyl-transferase from rat brain (purification, kinetic properties, development and distribution). J Neurochem (1972) 0.90
Activation and translocation of c-Src to the cytoskeleton by both platelet-derived growth factor and epidermal growth factor. J Biol Chem (1995) 0.90
Characterization of mutant subunits of human purine nucleoside phosphorylase. J Biol Chem (1978) 0.89
The effect of deoxyguanosine on human lymphocyte function. I. Analysis of the interference with lymphocyte proliferation in vitro. J Immunol (1984) 0.89
Neuroimages: local hyperhydrosis of the left forearm. Neurology (2000) 0.88
Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance. Cancer Res (1989) 0.88
Developing a comprehensive presurgical functional MRI protocol for patients with intractable temporal lobe epilepsy: a pilot study. Neuroradiology (2002) 0.88
Orotic aciduria in two unrelated patients with inherited deficiencies of purine nucleoside phosphorylase. J Clin Invest (1977) 0.88
Hypoxanthine-guanine phosphoribosyl transferase deficiency. Hum Genet (1976) 0.88
Generalized hexokinase deficiency in the blood cells of a patient with nonspherocytic hemolytic anemia. Blood (1983) 0.88
Sequence-, time- and dose-dependent synergism of methotrexate and 6-mercaptopurine in malignant human T-lymphoblasts. Biochem Pharmacol (1986) 0.88
Compartmentation of hexokinase in human blood cells. Characterization of soluble and particulate enzymes. Biochim Biophys Acta (1982) 0.87
Isozyme pattern of enolase of childhood tumors. Cancer (1984) 0.87
The influence of glucose I,6-diphosphate on the enzymatic activity of pyruvate kinase. Biochim Biophys Acta (1972) 0.87
Purine interconversion pathways in T, B, T gamma and T-T gamma cells from human peripheral blood. Adv Exp Med Biol (1984) 0.87
Compensatory mechanisms enhance hippocampal acetylcholine release in transgenic mice expressing human acetylcholinesterase. J Neurochem (2001) 0.87
Increased number of proliferating cells in oral epithelium from smokers and ex-smokers. Oral Oncol (1998) 0.86
Vascular effects of 5-HT1B/1D-receptor agonists in patients with migraine headaches. Clin Pharmacol Ther (2000) 0.86
Ritanserin, a 5-HT2 receptor blocker, as add-on treatment in narcolepsy. Sleep (1991) 0.86
Characteristics of hexokinase, pyruvate kinase, and glucose-6-phosphate dehydrogenase during adult and neonatal reticulocyte maturation. Am J Hematol (1985) 0.86
Standardization of an enzyme-linked immunosorbent assay for the determination of protein tyrosine kinase activity. Anal Biochem (1993) 0.86
Alanine inhibition of pyruvate kinase in gliomas and meningiomas. A diagnostic tool in surgery for gliomas? Lancet (1977) 0.86
Wilson's disease: modification by L-DOPA. Neuropadiatrie (1973) 0.86
Negative growth regulation of SK-N-MC cells by bFGF defines a growth factor-sensitive point in G2. J Biol Chem (2000) 0.85
Purification and properties of an abnormal glutathione reductase from human erythrocytes. Biochim Biophys Acta (1969) 0.85
Isozymes of pyruvate kinase from human brain, meningiomas, and malignant gliomas. Cancer Res (1978) 0.85
Mechanisms of deoxyguanosine toxicity for human T and B lymphocytes. Adv Exp Med Biol (1986) 0.84
Multiple membrane transport systems for the uptake of folate-based thymidylate synthase inhibitors. Cancer Res (1990) 0.84
Cyclin D3 regulates proliferation and apoptosis of leukemic T cell lines. J Biol Chem (1999) 0.84
Pathological and immunological observations in a case of Lesch-Nyhan-syndrome. Eur J Pediatr (1979) 0.84
Vigabatrin in the treatment of infantile spasms. Neuropediatrics (1993) 0.83
Characterization of some glycolytic enzymes from human retina and retinoblastoma. Cancer Res (1982) 0.83
Inhibition of cell proliferation by lithium is associated with interference in cdc2 activation. FEBS Lett (1999) 0.83
Alkyllysophospholipid ET-18-OCH3 acts as an activator of protein kinase C in HL-60 cells. FEBS Lett (1991) 0.83
Cranial and peripheral interictal vascular changes in migraine patients. Cephalalgia (2003) 0.83